Development of a highly sensitive LC–MS/MS method for simultaneous determination of rupatadine and its two active metabolites in human plasma: Application to a clinical pharmacokinetic study

Publication date: 10 July 2015 Source:Journal of Pharmaceutical and Biomedical Analysis, Volume 111 Author(s): Chenglong Sun , Qian Li , Liping Pan , Bing Liu , Pan Gu , Junying Zhang , Li Ding , Chungyong Wu An easy LC–ESI–MS/MS method was developed and validated for simultaneous determination of rupatadine (RT) and its two active metabolites, namely desloratadine (DT) and 3-hydroxydesloratadine (3-OH-DT), in human plasma. The chromatographic separation was carried out on a C18 column with gradient elution by using methanol and 10mM ammonium acetate containing 0.1% (v/v) formic acid. The lower limit of quantification (LLOQ) was 0.05, 0.035 and 0.035ng/mL for RT, DT and 3-OH-DT, respectively. The intra- and inter-day precision of analytes were within the range of 1.0–4.7% and 2.2–12.1%, respectively. The intra- and inter-day accuracy of analytes were within the range of −7.7% to 5.2% and −4.1% to 4.8%, respectively. The method was successfully applied to a pharmacokinetic study of RT and its two metabolite DT and 3-OH-DT in healthy volunteers following single (10, 20, 40mg) and multiple (10mg) oral doses of rupatadine fumarate tablets. Graphical abstract
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research